@hbnygaard
 North Vancouver
Joined July 2016
  • Tweets48
  • Following26
  • Followers88
6Media
Not sure anyone's solved this problem: merging your Apple calendars into one you can share. Some apps do it, but my work blocks anything that logs into my Exchange. So I built one that needs no login — if you have this problem, take a look. Works great: calendsapp.com

Calends, Many Apple calendars. One to share.

Combine work, school, and family calendars into one shareable master calendar. No accounts, no servers, everything stays in Apple's ecosystem.

calendsapp.com
28
Health Canada approves drug that slows progression of Alzheimer’s disease - The Globe and Mail apple.news/A2Mq_yHLPRPSFYXf-…

Health Canada approves drug that slows progression of Alzheimer’s disease

The medication is designed to affect the root cause of the disease, rather than just mitigate symptoms

apple.news
30
Lecanemab, a monoclonal antibody against amyloid-beta, was just approved by Health Canada for clinical use as a treatment for Alzheimer’s disease.
44
Haakon Nygaard retweeted
Laver Cup
@LaverCup22 Sep 2023
During the Next Generation Development Program hosted by UNIQLO, Roger Federer coached some of Canada’s most talented junior players. These young players got to experience playing with @rogerfederer and Severin Luthi on the Laver Cup court. #LaverCup | @UQAmbassadors
13
193
22
1,047
77,156
Blog post alert! drdemystified.com/dementia-1…

Dementia 101 – What you need to know to get the most out of this blog

A plain-language primer on what 'dementia' really means, how it's diagnosed, the main types, and how research moves from the lab toward a cure.

drdemystified.com
1
182
A little bit of good news: Your risk of dementia is getting lower. A lot lower. drdemystified.com/your-risk-…

A little bit of good news: Your risk of dementia is getting lower. A lot lower.

More people are affected by dementia than ever — yet each person's individual risk is actually falling, and by a surprising amount. Here's what the data shows, and why.

drdemystified.com
1
181
The first new drug for Alzheimer's in 25 years is here. Who is it for and how effective is it? drdemystified.com/the-first-…

The first new drug for Alzheimer's in 25 years is here. Who is it for and how effective is it?

Lecanemab is the first genuinely new Alzheimer's drug in 25 years. Who is it for, how well does it actually work, and what are the risks? A clear-eyed look at the evidence.

drdemystified.com
1
159
I’ve started a blog to explain the latest dementia research and other related topics to the public. Feel free to share! drdemystified.com

Dementia Research — Demystified

Clear, trustworthy explanations of the latest dementia and Alzheimer's research — written for curious minds, not just scientists.

drdemystified.com
1
144
This is big news and, regardless of relatively modest treatment effects, a paradigm shift in how we approach Alzheimer’s
The New York Times
@nytimes6 Jul 2023
Breaking News: The FDA gave full approval to the Alzheimer’s drug Leqembi, and Medicare said it would cover much of its high cost, laying the foundation for widespread use of the medication. nyti.ms/3rc2OQN
A card reads: "New Federal Decisions Make Alzheimer’s Drug Widely Accessible: The FDA’s decision marks the first time in two decades that a drug for Alzheimer’s has received full approval from the agency."

ALT A card reads: "New Federal Decisions Make Alzheimer’s Drug Widely Accessible: The FDA’s decision marks the first time in two decades that a drug for Alzheimer’s has received full approval from the agency."

167
1
184
1
159
facebook.com/100064600932985…

Canadian Seniors Tennis

Canadian team at the Opening Ceremonies of the ITF World Masters Team Championships in Turkey. Go Canada Go!

facebook.com
105
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment | FDA fda.gov/news-events/press-an…
166
Haakon Nygaard retweeted
The New York Times
@nytimes28 Sep 2022
Breaking News: The pharmaceutical companies Biogen and Eisai said on Tuesday that a drug they are developing for Alzheimer’s disease had slowed the rate of cognitive decline in a large late-stage clinical trial. nyti.ms/3rbdn3q

Alzheimer’s Drug Slows Cognitive Decline in Key Study (Published 2022)

Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.

nytimes.com
70
786
82
5,041
Haakon Nygaard retweeted
Roger Federer
@rogerfederer15 Sep 2022
To my tennis family and beyond, With Love, Roger

To my tennis family and beyond..

24,601
128,153
61,491
699,664
Haakon Nygaard retweeted
Dr. Willerth@DrWillerth16 Aug 2021
I'm very excited to announce that my @CIHR_IRSC project grant on #3dprinting brain organoids with @TheElviraLab @hbnygaard @aspectbiosys and @Axolotl_Biosci was funded! @uvic @UVicECS @UVicResearch @UVicMedSciences
10
4
1
78
via @NYTimes nytimes.com/2021/06/07/healt…
Still time to register for our annual forum tomorrow! ubcalzheimerforum.ca

UBC Alzheimer Forum

We are thrilled to invite you to our 2023 Update on Alzheimer’s Disease. The annual forum is an opportunity for us to share our ongoing work at UBC towards new therapies and diagnostic tools for...

ubcalzheimerforum.ca
2
1
Very cool automated analysis using a deep learning model for sleep staging using ambulatory EEG by UBC Engineering Capstone group and in collaboration with Dr. McKeown at UBC: mdpi.com/1424-8220/21/10/331…

A Deep Learning Strategy for Automatic Sleep Staging Based on Two-Channel EEG Headband Data

Sleep disturbances are common in Alzheimer’s disease and other neurodegenerative disorders, and together represent a potential therapeutic target for disease modification. A major barrier for...

mdpi.com
3
Dying in a Leadership Vacuum | NEJM nejm.org/doi/full/10.1056/NE…
1
Load more